Investing.com - Boston Scientific (NYSE:BSX) reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Boston Scientific announced earnings per share of $0.37 on revenue of $2.75B. Analysts polled by Investing.com anticipated EPS of $0.3054 on revenue of $2.62B.
Boston Scientific shares are up 9.39% from the beginning of the year and are trading at $42.41 , down-from-52-week-high.They are under-performing the S&P 500 which is up 11.47% from the start of the year.
Boston Scientific follows other major Healthcare sector earnings this month
Boston Scientific's report follows an earnings beat by J&J on Tuesday, April 20, 2021, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.34 on revenue of $21.98B.
Abbott Labs had beat expectations on Tuesday, April 20, 2021 with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar